Arrowhead Pharmaceuticals
ARWR
#2190
Rank
A$12.84 B
Marketcap
A$91.75
Share price
-0.19%
Change (1 day)
188.29%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): A$0.23 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are A$0.82 Billion. In 2024 the company made an earning of -A$0.86 Billion a decrease over its 2023 earnings that were of -A$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.23 B-127.22%
2024 -A$0.86 Billion112.45%
2023 -A$0.41 Billion87.79%
2022 -A$0.22 Billion-20.1%
2021 -A$0.27 Billion67.59%
2020 -A$0.16 Billion-347.53%
2019 A$64.55 M-245.59%
2018 -A$44.34 Million-13.17%
2017 -A$51.07 Million-52.28%
2016 -A$0.11 Billion-16.57%
2015 -A$0.13 Billion30.32%
2014 -A$98.43 Million171.62%
2013 -A$36.24 Million16.56%
2012 -A$31.09 Million107.53%
2011 -A$14.98 Million
2008 -A$52.77 Million-8.07%
2007 -A$57.4 Million70.37%
2006 -A$33.69 Million122.51%
2005 -A$15.15 Million147.41%
2004 -A$6.12 Million2002.28%
2003 -A$0.3 Million-85.61%
2002 -A$2.03 Million1371.97%
2001 -A$0.14 Million-13.45%
2000 -A$0.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.07 B 22,893.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.48 Billion-2,332.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$94.98 M-52.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-183.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.18 B-7.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-A$0.16 Billion-176.72%๐Ÿ‡บ๐Ÿ‡ธ USA